Those ever-present TV drug ads showing patients hiking, biking or enjoying a day at the beach could soon have a different ...
A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting the drug.
WASHINGTON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious ...
Boeing is starting to show progress in its turnaround plans. Shares of the plane maker closed at $139.10 on Wednesday, the first time shares have closed below $140 since October 2022 and below the ...